We are glad to announce that PHIL Inter Pharma has successfully received the first Marketing Authorization 

in Europe (UK and Ireland) for Ibuprofen 200 mg softgel capsule in December, 2018.

The 2^nd and 3^rd product, Dutasteride 0.5 mg and Ibuprofen 400 mg softgel capsules are planned to be filed 

in the European countries respectively, in the first and second quarter of 2019.

Again, we are glad that we took the first step to develop the partnership with our European customers 

and will do our best to further expand our portfolio for our customers.